[HTML][HTML] Covalent strategies for targeting messenger and non-coding RNAs: an updated review on siRNA, miRNA and antimiR conjugates

S Grijalvo, A Alagia, AF Jorge, R Eritja - Genes, 2018 - mdpi.com
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates

S Grijalvo, A Alagia, AF Jorge, R Eritja - Genes, 2018 - pubmed.ncbi.nlm.nih.gov
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates

S Grijalvo, A Adagia, AF Jorge, R Eritja Casadellà - 2018 - digital.csic.es
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.

S Grijalvo, A Alagia, AF Jorge, R Eritja - Genes, 2018 - search.ebscohost.com
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates

S Grijalvo, A Alagia, AF Jorge, R Eritja - Genes, 2018 - search.proquest.com
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

Covalent strategies for targeting messenger and non-coding RNAs: an updated review on siRNA, miRNA and antimiR conjugates

S Grijalvo, A Alagia, A Jorge, R Eritja - Genes, 2018 - ora.ox.ac.uk
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

[PDF][PDF] Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates

S Grijalvo, A Alagia, AF Jorge, R Eritja - pdfs.semanticscholar.org
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.

S Grijalvo, A Alagia, AF Jorge, R Eritja - Genes, 2018 - europepmc.org
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

[HTML][HTML] Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates

S Grijalvo, A Alagia, AF Jorge, R Eritja - Genes, 2018 - ncbi.nlm.nih.gov
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …

Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates

S Grijalvo, A Alagia, AF Jorge, R Eritja - Genes, 2018 - estudogeral.uc.pt
Oligonucleotide-based therapy has become an alternative to classical approaches in the
search of novel therapeutics involving gene-related diseases. Several mechanisms have …